Shares of Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY – Get Free Report) gapped up before the market opened on Friday . The stock had previously closed at $10.92, but opened at $11.5690. Santen Pharmaceutical shares last traded at $11.5690, with a volume of 313 shares trading hands.
Santen Pharmaceutical Stock Up 5.9%
The firm has a 50 day simple moving average of $12.27 and a 200-day simple moving average of $11.71.
About Santen Pharmaceutical
Santen Pharmaceutical Co, Ltd. is a Japan‐based specialty pharmaceutical company focused exclusively on ophthalmology. Headquartered in Osaka, Santen engages in the research, development, manufacture and marketing of prescription and over‐the‐counter products for the diagnosis and treatment of eye diseases. Its core product portfolio includes therapies for glaucoma, dry eye, retinal disorders, uveitis and post‐operative care, as well as surgical equipment and diagnostic agents designed to support comprehensive eye care.
With roots tracing back to the late 19th century, Santen has grown from a domestic manufacturer to a global ophthalmic specialist.
Further Reading
- Five stocks we like better than Santen Pharmaceutical
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for Santen Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Santen Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
